Search

Author/Creator Maisonobe, Pascal

11. An international, multicenter, prospective, randomized, evaluator-blinded study comparing differenT botulinum toxin injection strategies for treatment of upper limb spasticity. (25th December 2016)

Authors:
Rekand, Tiina; Biering-Sørensen, Bo; He, Jun; Vilholm, Ole Jakob; Christensen, Peter Brøgger; Ulfarsson, Trandur; Ström, Torbjörn; Myrenfors, Peter; Maisonobe, Pascal; Belusa, Roger; Dalager, Torben
Journal:
Toxicon
Issue:
Volume 123(2016)
Page Start:
S69
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. Assessing the Effectiveness of AbobotulinumtoxinA Injections for Adult Lower Limb Spasticity in Routine Clinical Practice: Methodology and Baseline Data for the AboLiSh Study. (July 2022)

Authors:
Esquenazi, Alberto; Zorowitz, Richard D.; Ashford, Stephen; Calvi-Gries, Francoise; Maisonobe, Pascal; Page, Simon; Jacinto, Jorge
Journal:
Toxicon
Issue:
Volume 214(2022)Supplement 1
Page Start:
S16
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. Botulinum toxin treatment of spasticity targeted to muscle endplates: an international, randomised, evaluator-blinded study comparing two different botulinum toxin injection strategies for the treatment of upper limb spasticity. Issue 5 (5th May 2019)

Authors:
Rekand, Tiina; Biering-Sörensen, Bo; He, Jun; Vilholm, Ole Jakob; Christensen, Peter Brøgger; Ulfarsson, Trandur; Belusa, Roger; Ström, Torbjörn; Myrenfors, Peter; Maisonobe, Pascal; Dalager, Torben
Other Names:
Rekand Tiina author non-byline.; Biering-sörensen Bo author non-byline.; He Jun author non-byline.; Vilholm Ole Jakob author non-byline.; Christensen Peter Brøgger author non-byline.; Ulfarsson Trandur author non-byline.; Belusa Roger author non-byline.; Ström Torbjörn author non-byline.; Myrenfo...
Journal:
BMJ open
Issue:
Volume 9:Issue 5(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

16. Correlations between spasticity, goal attainment, and global assessment of benefits in patients with upper limb spasticity treated with botulinum toxin A. (25th December 2016)

Authors:
Dashtipour, Khashayar; Balcaitiene, Jovita; Ashford, Stephen; Jacinto, Jorge; Fheodoroff, Klemens; Maisonobe, Pascal; Turner-Stokes, Lynne
Journal:
Toxicon
Issue:
Volume 123(2016) Supplement
Page Start:
S20
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

18. Efficacy and safety of abobotulinumtoxinA in pediatric lower limb spasticity (PLLS): 2nd interim results from a Phase IV, prospective, observational, multicenter study. (January 2021)

Authors:
Gormley, Mark; Dabrowski, Edward; Tilton, Ann; Christian, Asare; Evans, Sarah Helen; Maisonobe, Pascal; Wietek, Stefan
Journal:
Toxicon
Issue:
Volume 190(2021)supplement 1
Page Start:
S28
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

19. Evaluation of urinary prostate cancer antigen‐3 (PCA3) and TMPRSS2‐ERG score changes when starting androgen‐deprivation therapy with triptorelin 6‐month formulation in patients with locally advanced and metastatic prostate cancer. (4th April 2014)

Authors:
Martínez‐Piñeiro, Luis; Schalken, Jack A.; Cabri, Patrick; Maisonobe, Pascal; de la Taille, Alexandre; Triptocare Study Group
Journal:
BJU international
Issue:
Volume 114:Number 4(2014:Oct.)
Page Start:
608
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗